Crystal Structure of Rat Carnitine Palmitoyltransferase II (CPT-II)

Overview

Journal Biochem Biophys Res Commun

Publisher Elsevier

Specialty Biochemistry

Date 2006 Jun 20

PMID 16781677

Citations 17

Authors

Yu-Shan Hsiao

Gerwald Jogl

Victoria Esser

Liang Tong

Affiliations

Soon will be listed here.

Abstract

Carnitine palmitoyltransferase II (CPT-II) has a crucial role in the beta-oxidation of long-chain fatty acids in mitochondria. We report here the crystal structure of rat CPT-II at 1.9A resolution. The overall structure shares strong similarity to those of short- and medium-chain carnitine acyltransferases, although detailed structural differences in the active site region have a significant impact on the substrate selectivity of CPT-II. Three aliphatic chains, possibly from a detergent that is used for the crystallization, were found in the structure. Two of them are located in the carnitine and CoA binding sites, respectively. The third aliphatic chain may mimic the long-chain acyl group in the substrate of CPT-II. The binding site for this aliphatic chain does not exist in the short- and medium-chain carnitine acyltransferases, due to conformational differences among the enzymes. A unique insert in CPT-II is positioned on the surface of the enzyme, with a highly hydrophobic surface. It is likely that this surface patch mediates the association of CPT-II with the inner membrane of the mitochondria.

Citing Articles

Carnitine palmitoyltransferase II (CPT II) deficiency responsible for refractory cardiac arrhythmias, acute multiorgan failure and early fatal outcome.

Serra G, Antona V, Insinga V, Morgante G, Vassallo A, La Placa S Ital J Pediatr. 2024; 50(1):67.

PMID: 38616285 PMC: 11017661. DOI: 10.1186/s13052-024-01632-x.

Balancing adipocyte production and lipid metabolism to treat obesity-induced diabetes with a novel proteoglycan from Ganoderma lucidum.

Wang Y, Yu F, Zheng X, Li J, Zhang Z, Zhang Q Lipids Health Dis. 2023; 22(1):120.

PMID: 37553709 PMC: 10408226. DOI: 10.1186/s12944-023-01880-6.

CPT2 K79 acetylation regulates platelet life span.

Fan X, Wang Y, Cai X, Shen Y, Xu T, Xu Y Blood Adv. 2022; 6(17):4924-4935.

PMID: 35728063 PMC: 9631617. DOI: 10.1182/bloodadvances.2021006687.

Detection of Early Onset Carnitine Palmitoyltransferase II Deficiency by Newborn Screening: Should CPT II Deficiency Be a Primary Disease Target?.

Mador-House R, Liu Z, Dyack S Int J Neonatal Screen. 2021; 7(3).

PMID: 34449523 PMC: 8395870. DOI: 10.3390/ijns7030055.

The role and therapeutic implication of CPTs in fatty acid oxidation and cancers progression.

Wang J, Xiang H, Lu Y, Wu T, Ji G Am J Cancer Res. 2021; 11(6):2477-2494.

PMID: 34249411 PMC: 8263643.

References

Anderson R . Carnitine palmitoyltransferase: a viable target for the treatment of NIDDM?. Curr Pharm Des. 1999; 4(1):1-16. View

Ramsay R, Gandour R, van der Leij F . Molecular enzymology of carnitine transfer and transport. Biochim Biophys Acta. 2001; 1546(1):21-43. DOI: 10.1016/s0167-4838(01)00147-9. View

Jogl G, Tao X, Xu Y, Tong L . COMO: a program for combined molecular replacement. Acta Crystallogr D Biol Crystallogr. 2001; 57(Pt 8):1127-34. DOI: 10.1107/s0907444901006783. View

Lenhard J, Gottschalk W . Preclinical developments in type 2 diabetes. Adv Drug Deliv Rev. 2002; 54(9):1199-212. DOI: 10.1016/s0169-409x(02)00092-3. View

Jogl G, Tong L . Crystal structure of carnitine acetyltransferase and implications for the catalytic mechanism and fatty acid transport. Cell. 2003; 112(1):113-22. DOI: 10.1016/s0092-8674(02)01228-x. View

Wu D, Govindasamy L, Lian W, Gu Y, Kukar T, Agbandje-Mckenna M . Structure of human carnitine acetyltransferase. Molecular basis for fatty acyl transfer. J Biol Chem. 2003; 278(15):13159-65. DOI: 10.1074/jbc.M212356200. View

Ramsay R, Naismith J . A snapshot of carnitine acetyltransferase. Trends Biochem Sci. 2003; 28(7):343-6. DOI: 10.1016/S0968-0004(03)00137-3. View

Govindasamy L, Kukar T, Lian W, Pedersen B, Gu Y, Agbandje-Mckenna M . Structural and mutational characterization of L-carnitine binding to human carnitine acetyltransferase. J Struct Biol. 2004; 146(3):416-24. DOI: 10.1016/j.jsb.2004.01.011. View

Hsiao Y, Jogl G, Tong L . Structural and biochemical studies of the substrate selectivity of carnitine acetyltransferase. J Biol Chem. 2004; 279(30):31584-9. DOI: 10.1074/jbc.M403484200. View

10.

Steiber A, Kerner J, Hoppel C . Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med. 2004; 25(5-6):455-73. DOI: 10.1016/j.mam.2004.06.006. View

11.

Ramsay R, Zammit V . Carnitine acyltransferases and their influence on CoA pools in health and disease. Mol Aspects Med. 2004; 25(5-6):475-93. DOI: 10.1016/j.mam.2004.06.002. View

12.

Bonnefont J, Djouadi F, Prip-Buus C, Gobin S, Munnich A, Bastin J . Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med. 2004; 25(5-6):495-520. DOI: 10.1016/j.mam.2004.06.004. View

13.

Jogl G, Hsiao Y, Tong L . Crystal structure of mouse carnitine octanoyltransferase and molecular determinants of substrate selectivity. J Biol Chem. 2004; 280(1):738-44. DOI: 10.1074/jbc.M409894200. View

14.

Foster D . The role of the carnitine system in human metabolism. Ann N Y Acad Sci. 2004; 1033:1-16. DOI: 10.1196/annals.1320.001. View

15.

Jogl G, Hsiao Y, Tong L . Structure and function of carnitine acyltransferases. Ann N Y Acad Sci. 2004; 1033:17-29. DOI: 10.1196/annals.1320.002. View

16.

Ronnett G, Kim E, Landree L, Tu Y . Fatty acid metabolism as a target for obesity treatment. Physiol Behav. 2005; 85(1):25-35. DOI: 10.1016/j.physbeh.2005.04.014. View

17.

Rufer A, Thoma R, Benz J, Stihle M, Gsell B, De Roo E . The crystal structure of carnitine palmitoyltransferase 2 and implications for diabetes treatment. Structure. 2006; 14(4):713-23. DOI: 10.1016/j.str.2006.01.008. View

18.

Nicholls A, Sharp K, Honig B . Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins. 1991; 11(4):281-96. DOI: 10.1002/prot.340110407. View

19.

Jones T, Zou J, Cowan S, Kjeldgaard M . Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A. 1991; 47 ( Pt 2):110-9. DOI: 10.1107/s0108767390010224. View

20.

Otwinowski Z, Minor W . Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997; 276:307-26. DOI: 10.1016/S0076-6879(97)76066-X. View